Abstract
BI 905711, a tetravalent bispecific antibody that cross-links TRAILR2 with CDH17, leads to CDH17-dependent TRAILR2 oligomerization, resulting in caspase activation, apoptosis and tumour growth inhibition in preclinical GI cancer models.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
